32954-41-9 Usage
Molecular structure
2-(acetylamino)-3-[4-(acetyloxy)-3-methoxyphenyl]prop-2-enoic acid consists of a string of different functional groups, including an acetylamino group, a methoxy group, and an acetyloxy group.
Classification
It is a derivative of prop-2-enoic acid, classifying it as a carboxylic acid.
Drug category
It is a nonsteroidal anti-inflammatory drug (NSAID).
Therapeutic effects
The compound has analgesic (pain-relieving) and antipyretic (fever-reducing) properties.
Medical applications
It may be used to reduce pain and inflammation in conditions such as arthritis, menstrual cramps, and other types of pain.
Pharmacokinetics and bioavailability
The presence of the acetyloxy group in the compound may affect its pharmacokinetics (how the drug is absorbed, distributed, metabolized, and excreted) and bioavailability (the proportion of the drug that enters the bloodstream and is available to produce a therapeutic effect).
Check Digit Verification of cas no
The CAS Registry Mumber 32954-41-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,9,5 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 32954-41:
(7*3)+(6*2)+(5*9)+(4*5)+(3*4)+(2*4)+(1*1)=119
119 % 10 = 9
So 32954-41-9 is a valid CAS Registry Number.
32954-41-9Relevant academic research and scientific papers
SUBSTITUTED BETA-PHENYL-ALPHA-HYDROXY PROPANOIC ACID, SYNTHESIS METHOD AND USE THEREOF
-
Page/Page column 9, (2009/02/10)
The present invention relates to a compound of the formula (I), wherein R1, R2 and R3 are each independently selected from H, OH, F, Cl, Br, methoxy and ethoxy; or alternatively, R1 and R2 together form -OCH2O-, R3 is selected from H, OH, methoxy, ethoxy and halogens; R4 is OH or acyloxy; R5 is cycloalkoxyl, amino and substituted amino, and when R5 is selected from amino, at least one of R1, R2 and R3 is not H. The present invention further relates to a process for synthesizing a compound of the formula (I), and use of the compound of the formula (I) in the manufacture of a medicament for the prevention or treatment of cardiovascular or cerebrovascular diseases.
